PEStore

Family Office

Atar Capital

Atar Capital invests a family's own capital, often with no fixed holding period, from United States. It states a focus on healthcare & life sciences, business & professional services, consumer & retail and industrials & manufacturing.

Disclosed holdings15
Earliest stated investment2018
HeadquartersUnited States
Largest single fundNot stated

Stated investment criteria

What Atar Capital says it buys

Read from Atar Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Revenue it states$50m to $1.5bn1
Transaction typesPlatform, Add-on, Carve-out1
People listed on its team page52

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Atar Capital to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies Atar Capital lists on its own website. 9 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Microcel20188
WinCup20206
phade20206
BorgWarner North American Controls20215
Human Resource Training20215
Pathways Health and Community Support20215
Renew Consulting20215
Solero Technologies20215
Keypoint Intelligence20224
Clarvida
Frontier Integrity
InData Consulting
Pathway’s
RWS Facility Services
hrtaz.com

Compiled from Atar Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Recorded transactions

Buying and selling

Deals in which Atar Capital is named as buyer or seller in the transaction archive. 1 recorded exit, most recently in 2021.

CompanySideCounterpartyYearConsideration
RWSSoldQuest Resource2021$33m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Atar Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other family office investors active in healthcare & life sciences.